HCWB is trading about 8% down in after-hours at $2.18 as traders lock in profits following a massive 129.25% regular-session surge to $2.43.
- The reversal appears driven by short-term profit-taking and normalization after extreme speculative momentum in the thinly traded micro-cap biotech.
- No fresh fundamental news, earnings, or deal announcements have emerged, suggesting the move is primarily technical and sentiment-driven.
- The stock is retracing from its intraday peak in the absence of new company developments to sustain the rally.